Event Schedule

Have a look at Schedule

Day 1
Day 2

08:00

Registration & Itinerary Collection

08:50

Chairperson Welcome Address

Soroush Safaei

Senior Principal Scientist

Sanofi

09:00

Keynote Presentation: Science evolution drives pharma R&D Transformation

Claude Bertrand

Executive Vice President R&D

Servier

Next Generation Innovations

09:25

Presentation 1: Breakthroughs in neuroscience drug discovery : a wave of promising new and old therapeutics

Johan Luthman

EVP & Head R&D

Lundbeck

09:50

Presentation 2: Evaluating actionability of current and future insights from multi-omics Precision Medicine and AI. How not to buy the pig in the poke

Rudi Schmidt

COO

Institute for Healthier Living Abu Dhabi

10:15

Case Study Presentation: Psychedelic-inspired approaches for treating neurodegenerative disorders

Jekaterina Kaliniene, EMBA

Head of Life Sciences

Innovation Agency Lithuania

10:40

Coffee Break & Networking Session

Innovations in Cancer Therapeutics

11:30

Data Driven Presentation: The Naturopathic Treatment of Cancer and Chronic Diseases with immunotherapy via Immunomodulation

Eric Scheinbart M.D.

Immunity Redefined LLC

11:55

Spotlight Presentation: Immuno-oncology Breakthroughs:

Showcasing the latest developments in immunotherapy for cancer treatment

Dr. Neelima Khairatkar Joshi

President and Founder

Promethean Drug Ideas

12:15

Presentation 3: Senescence as a therapeutic target in oncology and age-related diseases

Dr. Timothy Cash

CSO

Rejuversen Europe SLU

12:40

Spotlight Presentation: Impact of modeling and simulation on the early drug discovery phases (hit to lead to candidate nomination). PROTAC (NX-2127, Nurix) case study

David Cebrian

Director DMPK Integrated Drug Discovery

Selvita

13:00

Lunch Break

14:00

Fish Bowl Conversation: Case Studies and Success Stories:

Real-world examples of successful drug discoveries
Lessons learned and best practices

Moderator

Soroush Safaei

Senior Principal Scientist

Sanofi

Panelists

Johan Luthman

EVP & Head R&D

Lundbeck

Eric Scheinbart M.D.

Immunity Redefined LLC

14:30

Team Tagged Presentation: Extensive study on anti-pain target using a dual antagonist

Dr. Sonali Das, Ph.D.

Director - Data Science

TCG LIFESCIENCES PRIVATE LIMITED

Dr. Sabyasachi Chakraborty

Senior Director - Biology

TCG LIFESCIENCES PRIVATE LIMITED

Dr. Arani Pal

Associate Vice President – Chemistry

TCG LIFESCIENCES PRIVATE LIMITED

Dr. Verena Mertes

Director Project Management

Labvantage - Biomax GmbH

Drug Fusion with AI & ML

14:50

Fireside Chat: The future of AI in shaping Drug Discovery

Moderator

Anna Puszkarska

Machine Learning Lead

Sanofi

Panelists

Fred Manby

Co-founder and CTO

Iambic Therapeutics

Dr. David Rios-Covian

CTO

Microviable Therapeutics

15:15

Spotlight Presentation: Accelerating Drug Discovery with Lab Informatics AI

Gabriele Magaro

Solutions Engineer

Sapio Sciences

15:35

Insightful Presentation: How Iambic uses AI to Drive a Drug Discovery Pipeline

Fred Manby

Co-founder and CTO

Iambic Therapeutics

15:55

Data Driven Presentation: Data Coverage in Public Drug Target Databases: Challenges and Solutions

Ziaurrehman Tanoli

Principal Investigator

Institute for Molecular Medicine Finland

16:15

Ground Breaking Research: Integrating Big Data and AI to Accelerate Hit-to-Lead Optimization

Shayoni Dutta

Data Science Manager

GSK

16:35

Last Glance: Machine Learning for Biological Molecule Design

Anna Puszkarska

Machine Learning Lead

Sanofi

16:55

Chair Closing Remarks

Soroush Safaei

Senior Principal Scientist

Sanofi

17:00

Happy Hour Networking

08:00

Registration & Itinerary Collection

08:50

Chair Welcome Address

Soroush Safaei

Senior Principal Scientist

Sanofi

Drug Delivery System

9:00

Ground Breaking Presentation: Advanced Injectable Drug Delivery Systems: Innovations and Future Trends

Devendra Ridhurkar, PhD

CEO

RidNova Pharmaceuticals

Microbiome Movement in Drug Discovery

09:25

Spotlight Presentation: Harnessing the Potential of Induced Pluripotent Stem Cells to Accelerate Drug Discovery for Age-Related Macular Degeneration

Florian Regent

Head of Ophthalmology Dept.

PHENOCELL SAS

09:45

Innovative Presentation: Exploring the Role of the Gut Microbiome in Cancer Drug Efficacy and Resistance

What is cancer and how do we treat it today?
Interactions between Gut Microbiome and Anti-Tumor Therapies
Microbial Therapeutics in Cancer: Present the latest developments in using microbiome-based strategies to improve cancer immunotherapies

Dr. Rafik FELLAGUE-CHEBRA, MD, MSc

Executive Global Group Medical Director

Novartis Oncology

10:10

Presentation 4: Developing Novel Biological Drugs For Infectious Diseases And Oncology Based On Our PharmaBiota (R) Platform

Claudio Hidalgo Cantabrana, PhD

CEO

Microviable Therapeutics

10:35

Coffee Break & Networking Session

Accelerating Drug Discovery

11:25

Presentation 5: The Relevance of High Throughput Screening in the Digital Age

Alex Alderton

Head of High Throughput Screening (HTS)

AstraZeneca

11:50

Presentation 6: Unlocking Therapeutic Frontiers: Ksilink's TechBio Approach to Accelerating Drug Discovery

Konstantinos Gkatzis

Head of Cardiovascular Research

KSILINK

12:15

Presentation 7: Benefits or early application of Biophysics in drug discovery

David Moreno Delgado

Director of Assay Development

Galapagos

12:40

Snap & Share Contest: Give attendees a few minutes to snap a picture that captures the essence of the conference or a specific theme. Share it on LinkedIn, tagging World BI. The photo with the most likes wins a Surprise Gift! Ready, set, SNAP!

12:50

Lunch Break

Business Perspective

13:50

Case Study Presentation: Building Successful Partnerships in the Life Sciences Industry

Nuno Alves, PhD

Associate Director

Astellas Europe

Synergies in Drug Discovery

14:20

Last Glance: First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G

Dr. Julien Caumartin

External Advisor

Melomanes

14:45